Ocular Therapeutix
OCUL
OCUL
108 hedge funds and large institutions have $301M invested in Ocular Therapeutix in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+2
Holders Change %
+1.89%
% of All Funds
2.18%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.1%
New
19
Increased
39
Reduced
30
Closed
16
Calls
$1.84M
Puts
$2.01M
Net Calls
-$166K
Net Calls Change
-$2.71M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10.7M |
| 2 |
BlackRock
New York
|
+$3.55M |
| 3 |
Two Sigma Advisers
New York
|
+$2.22M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.85M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.65M |
Top Sellers
| 1 |
CA
Corriente Advisors
Fort Worth,
Texas
|
-$6M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$3.14M |
| 3 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$2.6M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.58M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.13M |
